Authors: Tzachanis, D Freeman, GJ Hirano, N van Puijenbroek, AAFL Delfs, MW Berezovskaya, A Nadler, LM Boussiotis, VA

Citation: D. Tzachanis et al., Tob is a negative regulator of activation that is expressed in anergic andquiescent T cells, NAT IMMUNOL, 2(12), 2001, pp. 1174-1182

Authors: Boussiotis, VA Chen, ZM Zeller, JC Murphy, WJ Berezovskaya, A Narula, S Roncarolo, MG Blazar, BR

Citation: Va. Boussiotis et al., Altered T-cell receptor+CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease, BLOOD, 97(2), 2001, pp. 565-571

Authors: Boussiotis, VA Freeman, GJ Taylor, PA Berezovskaya, A Grass, I Blazar, BR Nadler, LM

Citation: Va. Boussiotis et al., p27(kip1) functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes, NAT MED, 6(3), 2000, pp. 290-297

Authors: Appleman, LJ Berezovskaya, A Grass, I Boussiotis, VA

Citation: Lj. Appleman et al., CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression, J IMMUNOL, 164(1), 2000, pp. 144-151

Authors: Boussiotis, VA Tsai, EY Yunis, EJ Thim, S Delgado, JC Dascher, CC Berezovskaya, A Rousset, D Reynes, JM Goldfeld, AE

Citation: Va. Boussiotis et al., IL-10-producing T cells suppress immune responses in anergic tuberculosis patients, J CLIN INV, 105(9), 2000, pp. 1317-1324